Lesion Volume Change After Treatment With Tissue Plasminogen Activator Can Discriminate Clinical Responders From Nonresponders

BACKGROUND AND PURPOSE: A change in acute-to-chronic lesion volume has been proposed as a biomarker for stroke therapies. The objectives of this study were to determine the magnitude of lesion volume change after standard treatment with tissue plasminogen activator and to determine whether specific...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Stroke
Asıl Yazarlar: Merino, José G., Latour, Lawrence L., Todd, Jason W., Luby, Marie, Schellinger, Peter D., Kang, Dong-Wha, Warach, Steven
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2007
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4747331/
https://ncbi.nlm.nih.gov/pubmed/17901392
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.107.485995
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller